252 related articles for article (PubMed ID: 8201250)
1. Dysthymia and serotonin.
Lapierre YD; Ravindran A; Bakish D
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():87-90. PubMed ID: 8201250
[No Abstract] [Full Text] [Related]
2. Serotonergic mechanisms and the new antidepressants.
Stahl SM
Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
[No Abstract] [Full Text] [Related]
3. [Is it feasible to develop a 5-HT basis for the treatment of depression?].
Hamon M
Encephale; 1995 Dec; 21 Spec No 4():27-32. PubMed ID: 8808343
[No Abstract] [Full Text] [Related]
4. Shifting depression.
Campbell IC; Marsden K; Powell JF
Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
[No Abstract] [Full Text] [Related]
5. Independent evaluation of new drugs.
Ball CJ
Br J Psychiatry; 1991 Oct; 159():586-7. PubMed ID: 1661200
[No Abstract] [Full Text] [Related]
6. [Current pharmacologic aspects of antidepressive agents].
Allain H
Encephale; 1994 Dec; 20 Spec No 4():710. PubMed ID: 7895642
[No Abstract] [Full Text] [Related]
7. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation].
Fillion G
Encephale; 1995 Feb; 21 Spec No 1():3-6. PubMed ID: 7729352
[No Abstract] [Full Text] [Related]
8. Venlafaxine: a novel antidepressant that has a dual mechanism of action.
Andrews JM; Ninan PT; Nemeroff CB
Depression; 1996; 4(2):48-56. PubMed ID: 9160640
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of action of antidepressants].
Llorca PM; Reine G; Wolf MA
Can J Psychiatry; 1993 Dec; 38(10):649-56. PubMed ID: 8313303
[TBL] [Abstract][Full Text] [Related]
10. Is there action beyond receptors?
Hrdina PD
J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
[No Abstract] [Full Text] [Related]
11. Preclinical pharmacology of citalopram.
Popik P
J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):4S-22S. PubMed ID: 10507505
[No Abstract] [Full Text] [Related]
12. [Antidepressive effectiveness and good tolerance].
Nervenarzt; 1997 Feb; 68(2 Suppl):5-7. PubMed ID: 9173321
[No Abstract] [Full Text] [Related]
13. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
Benkert O; Wetzel H; Szegedi A
Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
[No Abstract] [Full Text] [Related]
14. [Antidepressant agents in the therapy of severe depression in adolescents].
Marttunen M; Aalberg V
Duodecim; 1999; 115(1):36-44. PubMed ID: 11830858
[No Abstract] [Full Text] [Related]
15. Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls.
Lawrence KM; De Paermentier F; Lowther S; Crompton MR; Katona CL; Horton RW
J Psychiatry Neurosci; 1997 May; 22(3):185-91. PubMed ID: 9183117
[TBL] [Abstract][Full Text] [Related]
16. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
Blier P; de Montigny C
Biol Psychiatry; 1998 Sep; 44(5):313-23. PubMed ID: 9755353
[TBL] [Abstract][Full Text] [Related]
17. Holding on: depression, sensitization by antidepressant drugs, and the prodigal experts.
Fava GA
Psychother Psychosom; 1995; 64(2):57-61. PubMed ID: 8559954
[No Abstract] [Full Text] [Related]
18. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
Warrington SJ
Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
[TBL] [Abstract][Full Text] [Related]
19. Serotonin syndrome induced by administration of venlafaxine and phenelzine.
Heisler MA; Guidry JR; Arnecke B
Ann Pharmacother; 1996 Jan; 30(1):84. PubMed ID: 8773172
[No Abstract] [Full Text] [Related]
20. Antidepressants and side effects.
Carter G
Aust N Z J Psychiatry; 1995 Jun; 29(2):337. PubMed ID: 7487802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
